Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001851416-25-000004·China SXT Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
CHINA SXT PHARMACEUTICALS IN
Common stock, $0.08 par value · CUSIP: G2161P140
Event date: 2025-01-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Streeterville Capital LLC
Shares: 0.00 · Class: 0.0%
- Streeterville Management LLC
Shares: 0.00 · Class: 0.0%
- John M Fife
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001851416-25-000004
- Form type
- SCHEDULE 13G/A
- Filer
- China SXT Pharmaceuticals, Inc.
- CIK
- CIK 1723980
- Filed
- Jan 21, 2025
- Reporting period
- Jan 17, 2025
- Description
- Schedule 13G beneficial ownership